ArticleFrontiers in medicine2025
Efficacy analysis of serum ferritin, Hcy, CRP combined with fat ultrasound parameters in predicting metabolic dysfunction-associated steatotic liver disease.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- U-shaped relationship of plasma homocysteine with new-onset metabolic dysfunction-associated steatotic liver disease: a cohort study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the efficacy of combined prediction of serum ferritin, Hcy, CRP, and fat ultrasound parameters in metabolic dysfunction-associated steatotic liver disease (MASLD). Methods: One hundred and two MASLD patients admitted to our hospital from November, 2021 to November, 2023 were selected as the MASLD group, and 106 healthy subjects were selected as healthy group on the basis of the principle of 1:1, and the healthy group was not accompanied by any basic diseases. The differences in demographic data, medical records and biochemical indicators between the MASLD group and the healthy group were analyzed by single factor analysis. The suspected influencing factors of MASLD were screened by single factor analysis. Apply multivariate Logistic regression to examine the independent predictors of MASLD. Employ ROC curve to anticipate the effect of single and combined indicators. Results: Single factor analysis revealed that the SF, Hcy, CRP, and CAP level in MASLD group were significantly higher than healthy control group ( Conclusion: The combined application of serum SF, Hcy, CRP, and CAP has a high predictive efficiency for MASLD, which can be employed as an important reference indicator for early clinical diagnosis and intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.